Robert E. Drolet

A highly reproducible rotenone model of Parkinson's disease

Jason R. Cannon, Vı́ctor Tapias, Hye Mee Na et al. · Neurobiology of Disease · 2009 · 774 citations · Full text

Parkinson Disease, Neurochemical Biomarkers, Neurology +4

Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology

Robert E. Drolet, Jason R. Cannon, Laura Montero et al. · Neurobiology of Disease · 2009 · 249 citations · Full text

Experimental Neuropathology, Chronic Rotenone Exposure, Neuroprotection +4

Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem Cells

Marija Usenovic, Shahriar Niroomand, Robert E. Drolet et al. · Journal of Neuroscience · 2015 · 248 citations · Full text

TMEM175 deficiency impairs lysosomal and mitochondrial function and increases α-synuclein aggregation

Sarah Jinn, Robert E. Drolet, Paige E. Cramer et al. · Proceedings of the National Academy of Sciences · 2017 · 236 citations · Full text

Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity

Jack D. Scott, Duane E. DeMong, Thomas J. Greshock et al. · Journal of Medicinal Chemistry · 2017 · 140 citations · Full text

Drug Target, Pharmacotherapy, Medicinal Chemistry +16